Reproducibility of preclinical animal research improves with heterogeneity of study samples.
Single-laboratory studies conducted under highly standardized conditions are the gold standard in preclinical animal research. Using simulations based on 440 preclinical studies across 13 different interventions in animal models of stroke, myocardial infarction, and breast cancer, we compared the ac...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-02-01
|
Series: | PLoS Biology |
Online Access: | http://europepmc.org/articles/PMC5823461?pdf=render |
id |
doaj-5679d26a4f4343ba8baa40fcb8404bea |
---|---|
record_format |
Article |
spelling |
doaj-5679d26a4f4343ba8baa40fcb8404bea2021-07-02T05:23:40ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852018-02-01162e200369310.1371/journal.pbio.2003693Reproducibility of preclinical animal research improves with heterogeneity of study samples.Bernhard VoelklLucile VogtEmily S SenaHanno WürbelSingle-laboratory studies conducted under highly standardized conditions are the gold standard in preclinical animal research. Using simulations based on 440 preclinical studies across 13 different interventions in animal models of stroke, myocardial infarction, and breast cancer, we compared the accuracy of effect size estimates between single-laboratory and multi-laboratory study designs. Single-laboratory studies generally failed to predict effect size accurately, and larger sample sizes rendered effect size estimates even less accurate. By contrast, multi-laboratory designs including as few as 2 to 4 laboratories increased coverage probability by up to 42 percentage points without a need for larger sample sizes. These findings demonstrate that within-study standardization is a major cause of poor reproducibility. More representative study samples are required to improve the external validity and reproducibility of preclinical animal research and to prevent wasting animals and resources for inconclusive research.http://europepmc.org/articles/PMC5823461?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bernhard Voelkl Lucile Vogt Emily S Sena Hanno Würbel |
spellingShingle |
Bernhard Voelkl Lucile Vogt Emily S Sena Hanno Würbel Reproducibility of preclinical animal research improves with heterogeneity of study samples. PLoS Biology |
author_facet |
Bernhard Voelkl Lucile Vogt Emily S Sena Hanno Würbel |
author_sort |
Bernhard Voelkl |
title |
Reproducibility of preclinical animal research improves with heterogeneity of study samples. |
title_short |
Reproducibility of preclinical animal research improves with heterogeneity of study samples. |
title_full |
Reproducibility of preclinical animal research improves with heterogeneity of study samples. |
title_fullStr |
Reproducibility of preclinical animal research improves with heterogeneity of study samples. |
title_full_unstemmed |
Reproducibility of preclinical animal research improves with heterogeneity of study samples. |
title_sort |
reproducibility of preclinical animal research improves with heterogeneity of study samples. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Biology |
issn |
1544-9173 1545-7885 |
publishDate |
2018-02-01 |
description |
Single-laboratory studies conducted under highly standardized conditions are the gold standard in preclinical animal research. Using simulations based on 440 preclinical studies across 13 different interventions in animal models of stroke, myocardial infarction, and breast cancer, we compared the accuracy of effect size estimates between single-laboratory and multi-laboratory study designs. Single-laboratory studies generally failed to predict effect size accurately, and larger sample sizes rendered effect size estimates even less accurate. By contrast, multi-laboratory designs including as few as 2 to 4 laboratories increased coverage probability by up to 42 percentage points without a need for larger sample sizes. These findings demonstrate that within-study standardization is a major cause of poor reproducibility. More representative study samples are required to improve the external validity and reproducibility of preclinical animal research and to prevent wasting animals and resources for inconclusive research. |
url |
http://europepmc.org/articles/PMC5823461?pdf=render |
work_keys_str_mv |
AT bernhardvoelkl reproducibilityofpreclinicalanimalresearchimproveswithheterogeneityofstudysamples AT lucilevogt reproducibilityofpreclinicalanimalresearchimproveswithheterogeneityofstudysamples AT emilyssena reproducibilityofpreclinicalanimalresearchimproveswithheterogeneityofstudysamples AT hannowurbel reproducibilityofpreclinicalanimalresearchimproveswithheterogeneityofstudysamples |
_version_ |
1721338776620367872 |